Personalized Genetic Health and Cardiovascular:

• Enzyme replacement treatment for Type 1 Gaucher disease.
• Enzyme replacement treatment for Fabry disease.
• Enzyme replacement treatment for Mucopolysaccharidosis I (MPS I).
• Enzyme replacement treatment for Pompe disease.
• A cholesterol binding polymer

Renal:

• A unique calcium-free, metal-free phosphate binder indicated for the control of serum phosphorus in patients with Chronic Kidney Disease on hemodialysis.
• A vitamin D2 analogue indicated for the treatment of secondary hyperparathyroidism in patients with Chronic Kidney Disease Stages.

Biosurgery:

• A local therapy that provides lubrication for the knee joint and helps to reduce or to stop pain in an osteoarthritic knee.
• Autologous cultured chondrocytes to help repair damaged knee cartilage in patients with injuries caused by acute or repetitive trauma.

Hematology and Oncology:

• A humanized monoclonal antibody indicated for the treatment of B-cell chronic lymphocytic leukemia (B-CLL) in patients.
• A small molecule was granted marketing approval for the treatment of children with refractory or relapsed acute lymphoblastic leukemia (ALL). ALL is the most common form of pediatric leukemia
• Recombinant human hormone as an adjunctive diagnostic used in follow-up screenings of cancer patients with well-differentiated thyroid cancer who have had their thyroid glands removed.
• A small molecule used to mobilize stem cells from the bone marrow to the peripheral blood to facilitate harvesting by apheresis
• A chemotherapy drug used in the treatment of hematological malignancies
• An immunosuppressive polyclonal antibody that is used in conjunction with concomitant immunosuppression to treat acute rejection in transplant patients.